Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Memantine: a review of its use in Alzheimer's disease.

Robinson DM, Keating GM.

Drugs. 2006;66(11):1515-34. Review.

PMID:
16906789
2.
4.

Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

Thomas SJ, Grossberg GT.

Clin Interv Aging. 2009;4:367-77. Epub 2009 Oct 12. Review.

5.

Memantine: a review of its use in moderate to severe Alzheimer's disease.

McKeage K.

CNS Drugs. 2009 Oct;23(10):881-97. doi: 10.2165/11201020-000000000-00000. Review.

PMID:
19739697
6.

Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2005;23(2):193-206. Review.

PMID:
15748093
7.

Evaluation of memantine for the treatment of Alzheimer's disease.

Ferris SH.

Expert Opin Pharmacother. 2003 Dec;4(12):2305-13. Review.

PMID:
14640929
8.

Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

Sonkusare SK, Kaul CL, Ramarao P.

Pharmacol Res. 2005 Jan;51(1):1-17. Review.

PMID:
15519530
9.

Management of moderate to severe Alzheimer's disease: focus on memantine.

Dominguez E, Chin TY, Chen CP, Wu TY.

Taiwan J Obstet Gynecol. 2011 Dec;50(4):415-23. doi: 10.1016/j.tjog.2011.10.004. Review.

11.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
12.

Spotlight on memantine in moderate to severe Alzheimer's disease.

McKeage K.

Drugs Aging. 2010 Feb 1;27(2):177-9. doi: 10.2165/11204670-000000000-00000.

PMID:
20104942
13.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
14.

Once-daily memantine: a guide to its use in moderate to severe Alzheimer's disease in the EU.

Lyseng-Williamson KA, McKeage K.

Drugs Aging. 2013 Jan;30(1):51-8. doi: 10.1007/s40266-012-0041-0. Review.

PMID:
23229767
15.

[Efficacy of memantine in the treatment of Alzheimer's disease].

Molinuevo Guix JL, Lladó Plarrumaní A.

Neurologia. 2005 Dec;20(10):686-91. Review. Spanish.

PMID:
16317590
16.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res. 2012 Jul;9(6):746-58. Review.

17.

Use of memantine for the treatment of dementia.

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132. Review.

PMID:
21955192
18.

Memantine hydrochloride: pharmacological and clinical profile.

Möbius HJ, Stöffler A, Graham SM.

Drugs Today (Barc). 2004 Aug;40(8):685-95.

PMID:
15510240
20.

Memantine.

Jarvis B, Figgitt DP.

Drugs Aging. 2003;20(6):465-76; discussion 477-8. Review.

PMID:
12710865

Supplemental Content

Support Center